A carregar...
Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report
BACKGROUND: Fulminant myocarditis has been reported in patients treated with immune checkpoint inhibitors. We present the first described case of acute immune-mediated myocarditis and myositis associated with durvalumab plus tremelimumab combination therapy. The patient was undergoing treatment for...
Na minha lista:
| Publicado no: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005798/ https://ncbi.nlm.nih.gov/pubmed/29922709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2018.05.014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|